Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jun 2024

Ames Paul Rj, D'Andrea Giovanna, Arcaro Alessia, Marottoli Vincenzo, Iannaccone Luigi, Margaglione Maurizio, Gentile Fabrizio

Abstract excerpt

The aim of this study was to evaluate the impact of methylene tetrahydrofolate reductase (MTHFR) rs1801133 (C→T667 transition) on age at first idiopathic portal vein thrombosis (PVT) and to identify clinical and/or laboratory variables influencing age at first PVT, including plasma homocysteine and the prothrombin rs1799963 PT (G→A transition at position 20210) (PT) mutation. A retrospective cross-sectional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over
Share to Cross-Sectional Studies
Share to Homocysteine
Share to Homozygote
Share to Methylenetetrahydrofolate Reductase (NADPH2)
Share to Portal Vein
Share to Prothrombin
Share to Venous Thrombosis

Source

Identifiers

PMID: 38526965
DOI: 10.1097/MBC.0000000000001299

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type.PMID 38526965Read ↗

Homozygous Mthfr C677t Carriers Develop Idiopathic Portal Vein Thrombosis Twenty Years Earlier Than Wild TypeSemantic proximity Read ↗

Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.Semantic proximity Read ↗

Earlier onset of peripheral arterial thrombosis in homozygous MTHFR C677T carriers than in other MTHFR genotypes: a cohort study.Semantic proximity Read ↗

Thrombophilia testing in patients with portal vein thrombosis.Semantic proximity Read ↗

Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis.Semantic proximity Read ↗

Mesenteric-portal vein thrombosis in a patient with hyperhomocysteinemia and heterozygous for 20210A prothrombin allele.Semantic proximity Read ↗

Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type.Semantic proximity Read ↗

Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature.Semantic proximity Read ↗

Novel insights into the development of portal vein thrombosis in cirrhosis patients.Semantic proximity Read ↗

Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.Semantic proximity Read ↗

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.Semantic proximity Read ↗

The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.